{"retracted":true,"title":"ReACT Phase II trial: a critical evaluation of the use of rindopepimut plus bevacizumab to treat EGFRvIII-positive recurrent glioblastoma.","url":"http://doi.org/10.2217/cns.15.38","journal":"CNS oncology","update":"retracted"}
